Home › Calculator › LGNYZ Dividend Calculator 2026
LGNYZ DRIP Calculator & Dividend Yield 2026
2.16% YieldHealthcareLigand Pharmaceuticals Incorporated · OTC
Price: $0.04 · Annual div: $0.0008/share · Frequency: semi-annual · Payout ratio: N/A · Ex-div: 2026-06-26
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
LGNYZ Dividend Yield
LGNYZ (Ligand Pharmaceuticals Incorporated) has a dividend yield of 2.16%, based on an annual dividend of $0.0008 per share and a price of $0.04. Dividends are paid semi-annual.
LGNYZ DRIP Rate: How Many Shares Your Dividends Buy
With dividends reinvested, a LGNYZ position grows its share count by about 2.08% in the first year at today's price and yield.
| Year | Shares bought by dividends | Total shares | Dividend income |
|---|
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When LGNYZ pays your bills
Year your monthly dividend income covers each expense (based on current settings)
LGNYZ Dividend History — Last 2 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-06-26Latest | 2026-07-01 | $0.0025 | — | — |
| 2025-12-29 | 2026-01-02 | $0.0008 | 1.31% | $0.06 |
About Ligand Pharmaceuticals Incorporated (LGNYZ) — Dividend Analysis 2026
Ligand Pharmaceuticals Incorporated functions as a global biopharmaceutical entity, concentrating on the advancement and licensing of pharmaceutical assets. Its diverse portfolio includes commercial products targeting a wide array of serious health conditions. Key therapeutic offerings comprise Kyprolis and Evomela for the treatment of multiple myeloma, alongside Rylaze, an asparaginase formulation designed for both adult and pediatric patients battling acute lymphoblastic leukemia or lymphoblastic lymphoma. The company also provides Filspari, a dual endothelin and angiotensin II receptor antagonist, currently being developed for specific rare kidney diseases and as a non-immunosuppressive treatment for immunoglobulin A nephropathy. Further extending its reach, Ligand's portfolio features a teriparatide injection product for osteoporosis management. In the vaccine space, Vaxneuvance aims to prevent invasive disease caused by Streptococcus pneumoniae serotypes, while Pneumosil offers a pneumococcal conjugate vaccine primarily for children. A notable advancement is TZIELD, a CD3-directed antibody indicated to postpone the progression to Stage 3 type 1 diabetes in adults and children aged eight years and older who have Stage 2 T1D. Many of Ligand's solutions leverage its proprietary Captisol technology, enhancing drug formulations. Examples include Nexterone (a Captisol-enabled amiodarone), Zulresso (a Captisol-enabled brexanolone for postpartum depression), and Veklury, an antiviral treatment for moderate or severe COVID-19. The Captisol platform also supports Noxafil-IV, an IV formulation of posaconazole. Additional products in their repertoire address various indications such as post-menopausal symptoms (Duavee), autoimmune diseases (Exemptia), breast cancer (Vivitra), and other conditions through Bryxta and Zybev. Beyond its licensed therapies, Ligand also directly markets its Captisol materials. The company fosters strategic alliances, licenses, and business relationships with prominent pharmaceutical firms, including Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences, and Baxter International. Ligand Pharmaceuticals Incorporated, founded in 1987, maintains its headquarters in Jupiter, Florida.
LGNYZ Dividend & DRIP — Frequently Asked Questions
What is LGNYZ's dividend yield?
LGNYZ (Ligand Pharmaceuticals Incorporated) has a dividend yield of 2.16%, based on an annual dividend of $0.0008 per share and a price of $0.04. Dividends are paid semi-annual.
How much does $10,000 in LGNYZ pay in dividends?
$10,000 in LGNYZ at a 2.16% yield pays about $216 a year ($18 a month) before taxes. With DRIP, reinvested dividends buy more shares and that income compounds.
What is the DRIP rate for LGNYZ?
With dividends reinvested, a LGNYZ position grows its share count by about 2.08% in the first year at today's price and yield.
How do I calculate LGNYZ dividend reinvestment (DRIP) returns?
Enter your starting amount, monthly contribution and time horizon in the LGNYZ DRIP calculator at the top of this page. It reinvests each payout into new shares at the projected price, grows the dividend at the rate you choose and shows yearly income, share count, portfolio value and yield on cost. You can switch DRIP off to compare.
When is LGNYZ's next ex-dividend date?
LGNYZ's next ex-dividend date has not been announced yet; the most recent one was 2026-06-26. LGNYZ pays dividends semi-annual. Buy before the ex-dividend date to receive the next payment.
What is LGNYZ's dividend growth rate?
LGNYZ has less than a year of dividend history in our data, so there is no dividend growth rate yet.
Similar dividend stocks to LGNYZ
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full LGNYZ DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open LGNYZ position with:
🌍 LGNYZ Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold LGNYZ.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.16% | -0.64% | $216 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.84% | -0.96% | $184 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.73% | -1.07% | $173 / yr |
| 🇬🇧 UK ISA | 0% | 2.16% | -0.64% | $216 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1.97% | -0.83% | $197 / yr |
| 🇨🇦 TFSA | 0% | 2.16% | -0.64% | $216 / yr |
| 🇨🇦 CA Taxable | 25% | 1.62% | -1.18% | $162 / yr |
| 🇦🇺 Super (pension) | 15% | 1.84% | -0.96% | $184 / yr |
| 🇦🇺 AU Taxable | 30% | 1.51% | -1.29% | $151 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.59% | -1.21% | $159 / yr |
| 🇫🇷 FR Taxable | 30% | 1.51% | -1.29% | $151 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 LGNYZ Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 LGNYZ Dividend Payment Schedule
LGNYZ pays quarterly — 4 times per year. Ex-div: 2026-06-26.
📊 LGNYZ vs Healthcare Benchmarks
How LGNYZ compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for LGNYZ sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ LGNYZ Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare LGNYZ with peers: LGNYZ vs AMBD · LGNYZ vs ARPC · LGNYZ vs CHYPF
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the LGNYZ dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Ligand Pharmaceuticals Incorporated (LGNYZ) is currently trading at $0.04, trading near its 52-week high. The current dividend yield is 2.16% based on an annual payout of $0.0008 per share.
LGNYZ (Ligand Pharmaceuticals Incorporated) — 2.16% Dividend Yield Analysis
Ligand Pharmaceuticals Incorporated (LGNYZ) is a healthcare stock currently trading at $0.04 with a dividend yield of 2.16%. It pays an annual dividend of $0.0008 per share.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest LGNYZ News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
How investors use the LGNYZ dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.